MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-31-2025
Stryker Corporation Long-Term Debt 2011-2026 | SYK
Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.
Main characteristics:- Term exceeds 12 months
- Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
- Repaid through regular payments (interest and/or principal) over several years
- Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital. - Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks. - Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.
A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.
If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.
It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.
Examples of long-term debt:- Mortgage loans for property purchases
- Corporate bonds issued by a company to raise capital
- Project financing — long-term loans for building or expanding production facilities
- Leasing obligations for equipment or transport
Annual Long-Term Debt Stryker Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.2 B | 10.9 B | 11.9 B | 12.5 B | 13.2 B | 10.2 B | 8.49 B | 6.59 B | 6.69 B | 3.25 B | 3.25 B | 2.74 B | 1.75 B | 1.75 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.2 B | 1.75 B | 7.53 B |
Quarterly Long-Term Debt Stryker Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.8 B | 14.8 B | 14.4 B | 13.3 B | 10.1 B | 10.8 B | 10.4 B | 11.1 B | 11.9 B | 11.9 B | 12.8 B | - | 13.9 B | 12.5 B | 12.6 B | 12.7 B | 13.1 B | 13.2 B | 13.2 B | 13.2 B | 13.2 B | 10.2 B | 10.2 B | 10.2 B | 10.2 B | 8.49 B | 8.49 B | 8.49 B | 8.49 B | 6.59 B | 6.59 B | 6.59 B | 6.59 B | 6.69 B | 6.69 B | 6.69 B | 6.69 B | 3.23 B | 3.23 B | 3.23 B | 3.23 B | 3.25 B | 3.25 B | 3.25 B | 3.25 B | 2.74 B | 2.74 B | 2.74 B | 2.74 B | 1.75 B | 1.75 B | 1.75 B | 1.75 B | 1.75 B | 1.75 B | 1.75 B | 1.75 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 14.8 B | 1.75 B | 7.73 B |
Long-Term Debt of other stocks in the Medical devices industry
| Issuer | Long-Term Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
3.66 M | - | - | $ 17.2 B |  USA |
 |
Acutus Medical
AFIB
|
32.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
2.93 K | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
34 M | - | - | $ 475 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
24.1 M | $ 9.57 | 0.1 % | $ 687 M |  Israel |
 |
GenMark Diagnostics, Inc.
GNMK
|
71.3 M | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
575 M | $ 22.65 | -0.15 % | $ 3.24 B | USA |
 |
AxoGen
AXGN
|
47.5 M | $ 33.63 | 0.78 % | $ 1.49 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
7.56 M | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
33.2 M | $ 3.5 | 1.16 % | $ 121 M | USA |
 |
EDAP TMS S.A.
EDAP
|
2.16 M | $ 3.66 | -3.56 % | $ 136 M |  France |
 |
Electromed
ELMD
|
1.1 M | $ 28.9 | -0.41 % | $ 244 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
430 K | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.2 B | $ 323.76 | 1.47 % | $ 9.13 B | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
8.97 B | $ 97.6 | -0.79 % | $ 144 B | USA |
 |
CONMED Corporation
CNMD
|
905 M | $ 43.07 | -2.56 % | $ 1.33 B | USA |
 |
Conformis
CFMS
|
20.6 M | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
2.06 B | $ 54.12 | 3.12 % | $ 8.06 K | USA |
 |
Abbott Laboratories
ABT
|
12.6 B | $ 125.84 | -0.27 % | $ 219 B | USA |
 |
CryoLife, Inc.
CRY
|
290 M | - | -4.14 % | $ 702 M | USA |
 |
IRIDEX Corporation
IRIX
|
1.75 M | $ 1.16 | -2.94 % | $ 18.7 M | USA |
 |
Cardiovascular Systems
CSII
|
1.33 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
1.06 M | - | -10.19 % | $ 1.99 M | USA |
|
LENSAR
LNSR
|
2.09 M | $ 11.6 | -0.6 % | $ 134 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
154 K | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
38.6 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
7.64 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
1.11 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
11.9 M | - | - | $ 10.2 M | USA |
 |
Orthofix Medical
OFIX
|
157 M | $ 15.77 | -2.65 % | $ 601 M |  Curacao |
 |
Intersect ENT, Inc.
XENT
|
63.6 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
18 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
1.65 M | - | -0.57 % | $ 7.12 M | USA |
 |
Align Technology
ALGN
|
88.2 M | $ 172.23 | 0.97 % | $ 12.9 B | USA |
 |
Accuray Incorporated
ARAY
|
124 M | $ 0.89 | -0.47 % | $ 91.5 M | USA |
 |
IRadimed Corporation
IRMD
|
1.42 K | $ 98.81 | -1.19 % | $ 1.25 B | USA |
 |
Avinger
AVGR
|
1.1 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
3.01 M | $ 15.06 | -1.63 % | $ 407 M | USA |
 |
FONAR Corporation
FONR
|
155 K | $ 18.56 | 0.02 % | $ 122 M | USA |
 |
Sintx Technologies
SINT
|
3.69 M | $ 3.78 | -1.32 % | $ 14.1 M | USA |
 |
Sensus Healthcare
SRTS
|
398 K | $ 4.82 | 8.8 % | $ 78.6 M | USA |
 |
Globus Medical
GMED
|
298 K | $ 94.0 | -0.66 % | $ 12.8 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
760 M | $ 13.69 | -1.23 % | $ 1.05 B | USA |